Table 1. Participant characteristics for full sample and by AD risk group at study baseline.
Table values are mean (SD) or N (%). +Denotes a difference between CN and MCI, p<0.05, using t-test for continuous and Fisher’s exact test for categorical variables. ÂPOE genotype information unavailable for one participant.
| Variable | All (n=20) | CN (n=11) | MCI (n=9) |
|---|---|---|---|
| Age, years | 64.3 (6.3) | 64.9 (7.9) | 63.4 (4.0) |
| Female sex | 15 (75%) | 9 (81.8%) | 6 (66.7%) |
| Black race | 7 (35%) | 2 (18.2%) | 5 (55.6%) |
| APOE4-positive | 6 (31.6%) | 2 (20%)^ | 4 (44.4%) |
| Education, years | 16.1 (2.5) | 16.5 (2.3) | 15.7 (2.9) |
| BMI, kg/m2 | 28.4 (5.7) | 26.9 (6.2) | 30.3 (4.7) |
| MMSE | 28.7 (1.1) | 28.9 (1.0) | 28.3 (1.2) |
| Glucose, mg/dL | 97.6 (18.3) | 93.9 (11.4) | 102.1 (24.4) |
| BHB, mmol/L | 0.23 (0.27) | 0.35 (0.31)+ | 0.1 (0.14)+ |
| Insulin, μIU/mL | 8.3 (6.1) | 5.2 (3.4)+ | 12.0 (6.8)+ |
| HbA1c, % | 5.9 (0.3) | 5.9 (0.2) | 6.1 (0.4) |
| Total Chol, mg/dL | 215.2 (43.7) | 200.5 (42.1) | 233.2 (40.6) |
| HDL Chol, mg/dL | 67.4 (25.8) | 69.5 (25.8) | 64.8 (27.1) |
| VLDL Chol, mg/dL | 20.0 (11.1) | 15.2 (6.2)+ | 25.8 (13.2)+ |
| LDL Chol, mg/dL | 121.5 (41.2) | 104.1 (45.6)+ | 142.7 (24.2)+ |
| Triglycerides, mg/dL | 99.8 (55.7) | 75.5 (30.5)+ | 129.4 (66.4)+ |